ASHLEY HARTMAN: Open Payments
NPI 1285003806 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,257 in 51 payments from 27 companies in 2025. Trend: 2023 $258 · 2024 $874 · 2025 $1,257
Food & beverage: $1,257
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $194 |
| Astellas Pharma US Inc | 4 | $108 |
| Exelixis Inc. | 4 | $98 |
| PharmaEssentia USA Corporation | 2 | $67 |
| Dendreon Pharmaceuticals LLC | 2 | $61 |
| Janssen Biotech, Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| ABBVIE INC. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| SERVIER PHARMACEUTICALS LLC | 2 | $49 |
Products named: JEMPERLI, CABOMETYX, BESREMI, AYVAKIT, PROVENGE, Rubraca, Xtandi, ENHERTU.
Industry payments across TX — which companies pay providers there.
